rs10194475

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000090.4(COL3A1):​c.3202-40G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0357 in 1,604,162 control chromosomes in the GnomAD database, including 2,689 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.086 ( 1191 hom., cov: 31)
Exomes 𝑓: 0.031 ( 1498 hom. )

Consequence

COL3A1
NM_000090.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.25

Publications

4 publications found
Variant links:
Genes affected
COL3A1 (HGNC:2201): (collagen type III alpha 1 chain) This gene encodes the pro-alpha1 chains of type III collagen, a fibrillar collagen that is found in extensible connective tissues such as skin, lung, uterus, intestine and the vascular system, frequently in association with type I collagen. Mutations in this gene are associated with Ehlers-Danlos syndrome type IV, and with aortic and arterial aneurysms. [provided by R. Dalgleish, Feb 2008]
COL3A1 Gene-Disease associations (from GenCC):
  • autosomal dominant Ehlers-Danlos syndrome, vascular type
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
  • Ehlers-Danlos syndrome, vascular type
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • polymicrogyria with or without vascular-type Ehlers-Danlos syndrome
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 2-189006897-G-A is Benign according to our data. Variant chr2-189006897-G-A is described in ClinVar as Benign. ClinVar VariationId is 254968.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.233 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000090.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL3A1
NM_000090.4
MANE Select
c.3202-40G>A
intron
N/ANP_000081.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL3A1
ENST00000304636.9
TSL:1 MANE Select
c.3202-40G>A
intron
N/AENSP00000304408.4
COL3A1
ENST00000450867.2
TSL:1
c.3103-40G>A
intron
N/AENSP00000415346.2
COL3A1
ENST00000713745.1
c.3049-40G>A
intron
N/AENSP00000519049.1

Frequencies

GnomAD3 genomes
AF:
0.0854
AC:
12952
AN:
151714
Hom.:
1187
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.237
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.0439
Gnomad ASJ
AF:
0.0262
Gnomad EAS
AF:
0.00698
Gnomad SAS
AF:
0.0164
Gnomad FIN
AF:
0.0185
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0286
Gnomad OTH
AF:
0.0680
GnomAD2 exomes
AF:
0.0386
AC:
9699
AN:
250988
AF XY:
0.0346
show subpopulations
Gnomad AFR exome
AF:
0.241
Gnomad AMR exome
AF:
0.0282
Gnomad ASJ exome
AF:
0.0196
Gnomad EAS exome
AF:
0.00724
Gnomad FIN exome
AF:
0.0206
Gnomad NFE exome
AF:
0.0295
Gnomad OTH exome
AF:
0.0380
GnomAD4 exome
AF:
0.0305
AC:
44307
AN:
1452330
Hom.:
1498
Cov.:
29
AF XY:
0.0295
AC XY:
21310
AN XY:
723022
show subpopulations
African (AFR)
AF:
0.241
AC:
8019
AN:
33212
American (AMR)
AF:
0.0296
AC:
1322
AN:
44664
Ashkenazi Jewish (ASJ)
AF:
0.0200
AC:
522
AN:
26040
East Asian (EAS)
AF:
0.00607
AC:
240
AN:
39544
South Asian (SAS)
AF:
0.0145
AC:
1245
AN:
85986
European-Finnish (FIN)
AF:
0.0214
AC:
1140
AN:
53240
Middle Eastern (MID)
AF:
0.0418
AC:
235
AN:
5626
European-Non Finnish (NFE)
AF:
0.0265
AC:
29261
AN:
1103996
Other (OTH)
AF:
0.0387
AC:
2323
AN:
60022
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1833
3667
5500
7334
9167
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1150
2300
3450
4600
5750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0855
AC:
12983
AN:
151832
Hom.:
1191
Cov.:
31
AF XY:
0.0832
AC XY:
6173
AN XY:
74194
show subpopulations
African (AFR)
AF:
0.237
AC:
9804
AN:
41358
American (AMR)
AF:
0.0438
AC:
669
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.0262
AC:
91
AN:
3470
East Asian (EAS)
AF:
0.00699
AC:
36
AN:
5148
South Asian (SAS)
AF:
0.0162
AC:
78
AN:
4812
European-Finnish (FIN)
AF:
0.0185
AC:
195
AN:
10530
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0286
AC:
1942
AN:
67930
Other (OTH)
AF:
0.0673
AC:
142
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
504
1008
1511
2015
2519
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0531
Hom.:
136
Bravo
AF:
0.0934
Asia WGS
AF:
0.0230
AC:
83
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.4
DANN
Benign
0.61
PhyloP100
-1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10194475; hg19: chr2-189871623; API